Balolong, Rodjen .
HRN: 23-11-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/26/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/26/2023
06/05/2023
IV
500mg
TID
Culture-directed
Waiting Final Action
Indication: Culture-directed Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes